Concept Life Sciences, a science led business focused on delivering a comprehensive platform of services.

With over 300 years of cumulative medchem experience, Concept Life Sciences have wide-ranging knowledge, with particular expertise and success in; Oncology, Anti-infectives, CNS, Respiratory, Metabolic and Cardiovascular.

Our business is home to scientists with in-depth experience in their fields, who are enthusiastic about taking on challenges. We employ problem-solvers with a proven track record in the life sciences, laboratory based analytical testing and specialist consulting.

Find out more about us

You can trust Concept Life Sciences to deliver the science you need to support your project

Integrated Discovery &
Development Services

We offer a comprehensive range of integrated services to the pharmaceutical, biotechnology, agrochemical, chemical and consumer industries.

We also work closely with numerous academic groups. From first concept to IND and beyond, our expert scientists provide support every step of the way.

Analytical Solutions

From the environment we live in, to the air we breathe and the food we eat, our highly-experienced teams are equipped to deliver a wide range of testing, monitoring and analytical services.

We provide support and solve problems, ensuring compliance with industry and government regulations.

At Concept Life Sciences we have over 120 PhD scientists and world leading experts ready to support your project.

CHIEF TECHNICAL OFFICER GROUP TECHNICAL SERVICES

Dr Simon Bristow

CHIEF SCIENTIFIC OFFICER

Dr Paul Doyle

HEAD OF CHEMISTRY

Dr David Leese

HEAD OF BIOLOGY

Dr Chris Doe

Your partner in science

Today we have a fully integrated senior scientific leadership team with a highly experienced scalable team of scientists and project managers.

Our focus is on adding value to your project, problem solving, quality, collaboration, communication and flexibility.

View our proven track record

Latest News and Events

Featured News

Aquila BioMedical

Aquila BioMedical is now part of Concept Life Sciences. Aquila’s world-leading expertise focuses on the development of therapeutics for oncology, biomarker discovery, and target expression, with services covering a wide range of in-vitro and in-vivo proof-of-concept studies. The acquisition is a pivotal addition to the comprehensive range of integrated services Concept provides, supporting customers throughout the drug discovery and development process. www.aquila-bm.com.

Events
News